Literature DB >> 23202860

[Quality of life after treatment of head and neck tumors : longitudinal comparison after operation and adjuvant radio(chemo)therapy].

B M Bücheler1, A Ehnes, M Kavsadze, S Langenberg, T Wilhelm-Buchstab, M Zipfel, S Keiner, A O H Gerstner.   

Abstract

BACKGROUND: Quality of life is extraordinary affected by malignant tumors of the head and neck region as functions of social interaction are disturbed.
MATERIALS AND METHODS: The influence of surgical treatment and postoperative radio(chemo)therapy (RCT) on the quality of life was studied in patients with head and neck cancer. Twenty patients treated with curative intention completed the questionnaires EORTC QLQ-C30 and EORTC QLQ-H&N35 at three time points.
RESULTS: In most questions, patients reported poorer quality of life after RCT compared to postoperatively. Most of these differences were not significant. However, global quality of life and overall health was significantly worse after RCT as compared to postoperatively.
CONCLUSION: Both operation and postoperative RCT, lead to decreased quality of life in patients with a head and neck cancer. In comparison, RCT seems to have a more pronounced effect on the quality of life than operative therapy.

Entities:  

Mesh:

Year:  2012        PMID: 23202860     DOI: 10.1007/s00106-012-2628-5

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  20 in total

Review 1.  [Measuring quality of life in head and neck cancer. Current status and future needs].

Authors:  A Dietz; A Meyer; S Singer
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

2.  Quality of life and oral function following radiotherapy for head and neck cancer.

Authors:  J B Epstein; S Emerton; D A Kolbinson; N D Le; N Phillips; P Stevenson-Moore; D Osoba
Journal:  Head Neck       Date:  1999-01       Impact factor: 3.147

Review 3.  [Current status of head and neck cancer therapy in the elderly].

Authors:  A M Sesterhenn
Journal:  Laryngorhinootologie       Date:  2007-01-11       Impact factor: 1.057

4.  A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group.

Authors:  K Bjordal; A de Graeff; P M Fayers; E Hammerlid; C van Pottelsberghe; D Curran; M Ahlner-Elmqvist; E J Maher; J W Meyza; A Brédart; A L Söderholm; J J Arraras; J S Feine; H Abendstein; R P Morton; T Pignon; P Huguenin; A Bottomly; S Kaasa
Journal:  Eur J Cancer       Date:  2000-09       Impact factor: 9.162

5.  A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data.

Authors:  K Bjordal; M Ahlner-Elmqvist; E Hammerlid; M Boysen; J F Evensen; A Biörklund; M Jannert; T Westin; S Kaasa
Journal:  Laryngoscope       Date:  2001-08       Impact factor: 3.325

6.  ICF Core Set for head and neck cancer: do the categories discriminate among clinically relevant subgroups of patients?

Authors:  Uta Tschiesner; Cornelia Oberhauser; Alarcos Cieza
Journal:  Int J Rehabil Res       Date:  2011-06       Impact factor: 1.479

7.  Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.

Authors:  K Bjordal; E Hammerlid; M Ahlner-Elmqvist; A de Graeff; M Boysen; J F Evensen; A Biörklund; J R de Leeuw; P M Fayers; M Jannert; T Westin; S Kaasa
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

8.  Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients.

Authors:  K Bjordal; S Kaasa
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

Review 9.  Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review.

Authors:  Lisette van der Molen; Maya A van Rossum; Lori M Burkhead; Ludi E Smeele; Frans J M Hilgers
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-30       Impact factor: 2.503

10.  Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

Authors:  M J Hjermstad; S D Fossa; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.